India has three vaccines in advanced stages of trial. The vaccine candidate developed by Oxford University and AstraZeneca and proposed in India by Serum Institute is ahead and is set to enter phase 3. The other two locally developed candidates by Bharat Biotech and Cadila are in phase 2 trials.
from Times of India https://ift.tt/2FpwlPy
Sunday, 13 September 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment